D. Persons

发表

Chromosome-specific aneusomy in carcinoma of the breast.

L. Hartmann, R. Jenkins, R. Robinson, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma.

Marina N Nikiforova, Suzanne Kamel-Reid, M. Nikiforova, 2012, Archives of pathology & laboratory medicine.

Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.

D. Persons, P. Hsu, K. A. Borelli, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions.

D. Persons, K. A. Borelli, W. S. Croughan, 1998, Cancer genetics and cytogenetics.

Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.

D. Berry, L. Norton, D. Cowan, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists.

R. Tubbs, G. Dewald, J. Mascarello, 2006, Archives of pathology & laboratory medicine.

Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.

E. Yazlovitskaya, J. Pelling, Wei Cui, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Erratum: Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetics databases (Genetics in Medicine (2003) 5 (370-377))

G. Vance, A. Brothman, G. Dewald, 2003 .

Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetic databases [corrected].

G. Vance, A. Brothman, G. Dewald, 2003, Genetics in medicine : official journal of the American College of Medical Genetics.

As currently formulated, ISCN FISH nomenclature make it not practical for use in clinical test reports or cytogenetic databases

G. Vance, A. Brothman, G. Dewald, 2003, Genetics in Medicine.

Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia.

D. Persons, S. Ganguly, M. Cunningham, 2006, Cancer genetics and cytogenetics.

Cytogenetic studies of epithelial ovarian carcinoma.

L. Hartmann, K. Podratz, R. Jenkins, 1993, Cancer genetics and cytogenetics.

Twin pregnancy with partial hydatidiform mole and coexistent fetus.

Fang Fan, D. Persons, J. Chapman, 2004, Archives of pathology & laboratory medicine.

Cisplatin‐induced response of c‐jun N‐terminal kinase 1 and extracellular signal‐regulated protein kinases 1 and 2 in a series of cisplatin‐resistant ovarian carcinoma cell lines

E. Yazlovitskaya, J. Pelling, Wei Cui, 2000, Molecular carcinogenesis.

Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.

R. Jenkins, A. Alcaraz, M. Lieber, 1994, The Journal of urology.

Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma.

J. Katzmann, R. Jenkins, M. Lieber, 1994, Human pathology.

Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma.

J. Katzmann, R. Jenkins, G. Farrow, 1993, The Journal of urology.

Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

L. Hartmann, W. Cliby, R. Jenkins, 1993, The American journal of pathology.

Microgranular variant of acute promyelocytic leukemia with normal conventional cytogenetics, negative PML/RARA FISH and positive PML/RARA transcripts by RT-PCR.

R. Ketterling, R. McClure, S. Abhyankar, 2011, Cancer genetics.

Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization.

J. Sosman, M. Slovak, D. Arber, 2002, Cancer Detection and Prevention.

Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probes.

G. Vance, A. Brothman, G. Dewald, 2002, Archives of pathology & laboratory medicine.

Biclonal post-transplant B-cell lymphoma: report of a case with two distinct cell populations, XX,t(14;18) and XY,t(11;14).

P. Vanveldhuizen, Katie Dennis, S. Mathur, 2007, Cancer genetics and cytogenetics.

Myelodysplastic Syndrome with concomitant t(5;21)(q15;q22) and del(5)(q13q33): case report and review of literature.

S. Kambhampati, J. Woodroof, D. Persons, 2016, Stem cell investigation.

EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study

D. Persons, M. Jacobs, G. Fraga, 2013, Journal of cutaneous pathology.

Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study.

C. Tangen, M. Slovak, D. Wood, 2007, Cancer genetics and cytogenetics.

Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation.

D. Persons, Marilyn K. Davis, M. Cunningham, 2004, Archives of pathology & laboratory medicine.

Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature

J. McGuirk, D. Persons, S. Ganguly, 2009, International journal of hematology.

Clonal karyotypic aberrations in enchondromas.

J. Neff, J. Bridge, D. Persons, 1992, Cancer detection and prevention.

Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.

D. Taylor, T. Slotkin, D. Persons, 1984, Teratology.

Prolonged wild-type p53 protein accumulation and cisplatin resistance.

E. Yazlovitskaya, D. Persons, R. DeHaan, 2001, Biochemical and biophysical research communications.

Cytogenetic analysis of two sacral chordomas.

J. Neff, J. Bridge, D. Persons, 1991, Cancer genetics and cytogenetics.

Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.

D. Bostwick, R. Jenkins, A. Alcaraz, 1996, The Journal of urology.

Nomenclature Evolution: Changes in the ISCN from the 2005 to the 2009 Edition

L. Shaffer, A. Brothman, D. Persons, 2010, Cytogenetic and Genome Research.

Polyamines in brain and heart of the neonatal rat: effects of inhibitors of ornithine decarboxylase and spermidine synthase.

T. Slotkin, D. Persons, J. Bartolome, 1984, Life sciences.

Comparison of polymerase chain reaction, DNA hybridization, and histology with viral culture to detect cytomegalovirus in immunosuppressed patients.

J. Fishback, D. Persons, J. Moore, 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Effects of antimutagens on prophage induction in E coli lysogenic for lambda.

D. Shankel, D. Persons, 1983, Environmental mutagenesis.

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.

J. Doroshow, M. Slovak, F. Appelbaum, 2001, Blood.

Detection of Copy Number Alterations in Metastatic Melanoma by a DNA Fluorescence In situ Hybridization Probe Panel and Array Comparative Genomic Hybridization: A Southwest Oncology Group Study (S9431)

David D. Smith, V. Sondak, J. Sosman, 2008, Clinical Cancer Research.

Development of a syngeneic mouse model for events related to ovarian cancer.

J L Pace, O. Tawfik, K. Roby, 2000, Carcinogenesis.

Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines.

Raymond R Tubbs, Patrick L Fitzgibbons, K. Bloom, 2009, Archives of pathology & laboratory medicine.

Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.

L. Hartmann, R. Jenkins, G. Keeney, 1994, American journal of clinical pathology.

Form of 15q proximal duplication appears to be a normal euchromatic variant.

N. Lindor, G. Dewald, D. Persons, 1994, American journal of medical genetics.

College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis

K. Tsuchiya, A. Brothman, Jonathan P. Park, 2011, Genetics in Medicine.

Detection of Copy NumberAlterations in Metastatic Melanoma by a DNAFluorescence In situ Hybridization Probe Panel and Array Comparative Genomic Hybridization : A Southwest Oncology Group Study ( S 9431 )

David D. Smith, V. Sondak, J. Sosman, 2008 .

Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin*

E. Yazlovitskaya, J. Pelling, D. Persons, 2000, The Journal of Biological Chemistry.

Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene.

Daynna J Wolff, K. Theil, Diane L Persons, 2012, Archives of pathology & laboratory medicine.

Non-random loss of chromosome 3 during transition of Helicobacter pylori-associated gastric MALT to B-cell MALT lymphoma revealed by fluorescence in situ hybridization.

A. Weston, S. Banerjee, D. Persons, 1997, Cancer letters.

Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years.

S. Patil, G. Vance, A. Brothman, 2006, Archives of pathology & laboratory medicine.

Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease.

Suzanne Kamel-Reid, Lawrence J Jennings, S. Kamel‐Reid, 2012, Archives of pathology & laboratory medicine.

Test verification and validation for molecular diagnostic assays.

Iris Schrijver, I. Schrijver, K. Halling, 2012, Archives of pathology & laboratory medicine.

Human papillomavirus and carcinoma of the urinary bladder.

J. Fishback, D. Persons, S. Kerley, 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

A 26-Year-Old Female with Systemic Mastocytosis with Associated Myeloid Neoplasm with Eosinophilia and Abnormalities of PDGFRB, t(4;5)(q21;q33)

S. Ponnala, A. Yacoub, D. Persons, 2016, Case reports in hematology.

Quick-FISH: a rapid fluorescence in situ hybridization technique for molecular cytogenetic analysis.

A. Weston, S. Banerjee, D. Persons, 1998, BioTechniques.

Trisomy 4q Syndrome: A rare Syndrome Phenotypically Similar to Trisomy 18

S. Myers, D. Persons, T. Raghuveer, 2006 .

Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing.

R. Nagle, G. Vance, A. Brothman, 2002, Archives of pathology & laboratory medicine.

Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study.

M. Bui, S. Masood, M. Lowery, 2000, Annals of clinical and laboratory science.

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.

S. Johansson, J. Bridge, Jane S. Gibson, 2006, The Journal of urology.

BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression

D. Edwards, S. Hilsenbeck, Jeffrey A. Thompson, 2020, npj Breast Cancer.

BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression

D. Edwards, S. Hilsenbeck, Jeffrey A. Thompson, 2020, npj Breast Cancer.

Association of apoptosis with the inhibition of extracellular signal–regulated protein kinase activity in the tumor necrosis factor α‐resistant ovarian carcinoma cell line UCI 101

E. Yazlovitskaya, J. Pelling, D. Persons, 1999, Molecular carcinogenesis.

Complex karyotype in a low grade phyllodes tumor of the breast.

I. Damjanov, W. Jewell, D. Persons, 2002, Cancer genetics and cytogenetics.

D. Persons, O. Aljitawi, Sabita Pokhrel, 2016, Case reports in hematology.

Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests.

Rhona J. Souers, K. Tsuchiya, J. Bridge, 2018, Archives of pathology & laboratory medicine.

Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in‐situ hybridization in the evaluation of HER‐2/neu expression in primary breast carcinoma

P. Thomas, W. Jewell, D L Persons, 2006, Histopathology.

Clinical and Pathologic Correlation of Increased MYC Gene Copy Number in Diffuse Large B-Cell Lymphoma.

D. Persons, W. Cui, Da Zhang, 2016, Clinical lymphoma, myeloma & leukemia.

Multicentric renal angiomyolipoma associated with pulmonary lymphangioleiomyomatosis: case report, with histologic, immunohistochemical, and DNA content analyses.

D. Persons, M. Austenfeld, O. Tawfik, 1996, Urology.

Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase

E. Yazlovitskaya, D. Persons, R. DeHaan, 2001, Cancer Chemotherapy and Pharmacology.

Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.

E. Yazlovitskaya, D. Persons, 2003, Anticancer research.

Cisplatin‐induced response of c‐jun N‐terminal kinase 1 and extracellular signal‐regulated protein kinases 1 and 2 in a series of cisplatin‐resistant ovarian carcinoma cell lines

E. Yazlovitskaya, J. Pelling, Wei Cui, 2000, Molecular carcinogenesis.

Erratum: Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma (Archives of Pathology and Laboratory Medicine (2012) 136:1 (26-32))

M. Nikiforova, S. Kamel‐Reid, Tong Zhang, 2012 .